CSL LIMITED / CSL ASX Options Details

Health Care



Chart Period: Volatility: Put Call Ratio:

Pricing and Volatility

Option Volume and Put Call Ratio

CSL Limited is an Australian biotechnology company based in Parkville, Melbourne. Originally founded in 1916 under the name 'Commonwealth Serum Laboratories', the company was a Federal Government department until its privatisation in 1994. CSL researches and produces medical products used to treat medical conditions and operates on a global scale. Vaccines, antivenom and pharmaceutical products are among some of the products that CSL develops and markets. CSL offers both American and European style options.


At $135 per share, is CSL Limited still an opportunity?
Are CSL Limited (ASX:CSL) shares overpriced today?
If CSL Limited CEO Paul Perreault sneezes, Australia gets a cold

Company Search



Option List (European)


2017-06-29
2017-07-27
2017-08-24
2017-09-28
2017-12-21

Similar Stocks


ANN
RMD
SHL
RHC